Endocrine Abstracts

Introduction: Individual variability in drug efficacy and safety due to genetic diversity is a major challenge for clinicians. Pharmacogenetics deals with inherited differences in the efficacy and safety responses to drugs. The incidence of type 2 diabetes (T2D) is increasing worldwide and the disease is reaching pandemic proportions. T2D is treated by oral and/or injectable drugs. The interindividual variability of T2D drug actions may be caused, at least in part, by genetic ...